Pliant Therapeutics, Inc.
PLRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26,301 | -$43,300 | -$56,166 | -$49,732 |
| Dep. & Amort. | $436 | $447 | $448 | $458 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $6,378 | $8,913 | $8,417 |
| Change in WC | -$1,849 | -$6,920 | -$4,234 | -$8,181 |
| Other Non-Cash | $6,633 | $2,792 | $2,175 | $1,376 |
| Operating Cash Flow | -$21,081 | -$40,603 | -$48,864 | -$47,662 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$112 | -$262 | -$209 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$51,607 | -$14,149 | -$33,355 |
| Inv. Sales/Matur. | $0 | $87,206 | $83,525 | $72,696 |
| Other Inv. Act. | $27,921 | $0 | $0 | $0 |
| Investing Cash Flow | $27,921 | $35,487 | $69,114 | $39,132 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $1 |
| Stock Issued | $0 | $0 | $498 | $101 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $72 | $0 | $0 | $0 |
| Financing Cash Flow | $72 | $0 | $498 | $102 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $6,912 | -$5,116 | $20,748 | -$8,428 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88,302 | $93,418 | $71,188 | $81,098 |
| End Cash | $95,214 | $88,302 | $91,936 | $72,670 |
| Free Cash Flow | -$21,081 | -$40,715 | -$49,126 | -$47,871 |